The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...
Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...
In addition to the DTA Fibrosis Score, VIDA’s ILD offering enables the following trial services: • Enhanced eligibility assessments, supported by novel, patented visualizations, including Tomographic ...
Blood-based biomarkers and imaging measures may help monitor MASH disease activity, potentially reducing reliance on liver biopsies. Semaglutide treatment showed significant improvements in liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback